Regenxbio's chart shows bullish signals with Bollinger Bands expanding upward.

Regenxbio's 15-minute chart exhibits an upward-expanding Bollinger Bands pattern, accompanied by a bullish Marubozu candle at 09/22/2025 11:30. This indicates a dominant market trend driven by buyers, who are exerting control over the market, and suggests a continuation of bullish momentum.

Acadian Asset Management LLC has invested approximately $1.12 million in REGENXBIO Inc. (RGNX), acquiring 157,266 shares during the first quarter, which represents about 0.31% of the company Acadian Asset Management LLC Purchases Shares of 157,266 REGENXBIO Inc. $RGNX^[1]. This investment comes amid a mixed analyst sentiment, with ratings ranging from a "strong sell" to a "buy" rating and target prices between $17.00 and $52.00 Acadian Asset Management LLC Purchases Shares of 157,266 REGENXBIO Inc. $RGNX^[1].

The biotechnology company reported a loss of $1.38 EPS for the last quarter, significantly missing consensus estimates, with overall revenue coming in at $21.36 million compared to expected $40.87 million Acadian Asset Management LLC Purchases Shares of 157,266 REGENXBIO Inc. $RGNX^[1]. Despite the earnings miss, REGENXBIO's stock has experienced volatility, trading up 3.7% recently Acadian Asset Management LLC Purchases Shares of 157,266 REGENXBIO Inc. $RGNX^[1].

Analysts have mixed views on REGENXBIO's future prospects. Wall Street Zen cut the stock from a "hold" rating to a "strong sell" rating, while Chardan Capital and HC Wainwright reaffirmed a "buy" rating with price objectives of $52.00 and $34.00, respectively Acadian Asset Management LLC Purchases Shares of 157,266 REGENXBIO Inc. $RGNX^[1]. The consensus rating is "Moderate Buy" with a target price of $28.38 Acadian Asset Management LLC Purchases Shares of 157,266 REGENXBIO Inc. $RGNX^[1].

The 15-minute chart of REGENXBIO's stock exhibits an upward-expanding Bollinger Bands pattern, accompanied by a bullish Marubozu candle at 09/22/2025 11:30. This pattern indicates a dominant market trend driven by buyers, suggesting a continuation of bullish momentum .

Other institutional investors have also shown interest in REGENXBIO. FNY Investment Advisers LLC, Brooklyn Investment Group, Pallas Capital Advisors LLC, Entropy Technologies LP, and ProShare Advisors LLC have purchased new positions or increased their stakes in the company Acadian Asset Management LLC Purchases Shares of 157,266 REGENXBIO Inc. $RGNX^[1].

CEO Curran Simpson sold 7,734 shares of REGENXBIO stock, representing a 3.07% decrease in his position Acadian Asset Management LLC Purchases Shares of 157,266 REGENXBIO Inc. $RGNX^[1]. The company's market cap stands at $449.03 million, with a price-to-earnings ratio of -2.58 and a beta of 1.17 Acadian Asset Management LLC Purchases Shares of 157,266 REGENXBIO Inc. $RGNX^[1].